Oklahoma GeroScience Symposium 2021 
April 8 - April 9, 2021 

The 2021 Oklahoma GeroScience Symposium was our most successful by far.  We had over 242 participants, including 121 outside of Oklahoma and 4 outside of the United States!!  

We want to thank our speakers, moderators and hosts for all of their hard work and dedication to make this years' symposium a huge success!!

The Impact of Nutritional and Pharmacological Interventions on Healthspan and Age-Related Diseases


April 8-9, 2021

12:00 PM - 3:30 PM



Virtual Conference

Zoom link will be sent with Registration


The 2021 Oklahoma GeroScience Symposium focuses on recent advances using nutritional and pharmacological manipulations to extend the lifespan of mice and how these manipulations alter the healthspan and age-related diseases in mice. Dr. Jay Olshansky will be the keynote speaker and will describe estimates of the upper limits to human longevity and exploring the health and public policy implications associated with aging.

Oklahoma GeroScience Symposium

Keynote Speaker

S. Jay Olshansky, Ph.D.


School of Public Health

University of Illinois at Chicago

The Longevity Dividend: the economical and sociological impact of slowing aging.

Featured Speakers

Nutritional Interventions on Healthspan

Rafael deCabo, Ph.D.

Senior Investigator

Translational Gerontology Branch of the National Institute on Aging

Caloric restriction and time-restricted fasting on aging and healthspan.

Rozalyn Anderson, Ph.D.

Associate Professor Medicine

University of Wisconsin

Effect of caloric restriction on non-human primates.

Archana Unnikrishnan, Ph.D.

Assistant Professor of Biochemistry & Molecular Biology

University of Oklahoma Health Sciences Center

How universal is the effect of caloric restriction on lifespan: the effect of dietary restriction on four RI-lines of mice.

Richard Miller, M.D./Ph.D.

Professor of Pathology and Director of the University of Michigan Glenn Center for Aging Research

University of Michigan

Effects of acarbose on longevity and healthspan.

Pharmacological Interventions on Healthspan

Shin-ichiro Imai, M.D./Ph.D.

Professor of Developmental Biology
Washington University School of Medicine

Achieving Productive Aging: the mechanism of aging/longevity control in mammals and anti-aging intervention.

Veronica Galvan, Ph.D.

Associate Professor of Physiology

University of Texas Health Science Center at San Antonio

Effect of rapamycin on the aging brain and neurodegeneration.

Mike Stout, Ph.D.

Assistant Professor of Nutritional Sciences

University of Oklahoma Health Sciences Center

The role of the estrogen receptor-a in male disease burden and responsiveness to 17a-estradiol.

Peter Rabinovitch, M.D./Ph.D.

Professor of Pathology and Director of the Nathan Shock Center for Excellence in the Basic Biology of Aging

University of Washington

Effects of SS-peptide and nicotinamide mononucleotide on heart function.

Laura Niedernhofer, Ph.D.

Professor of Biochemistry, Molecular Biology & Biophysics and Director of the Institute of Biology of Aging and Metabolism

University of Minnesota

The use of senolytics as a therapy to improve healthspan.

​Need More Information?

​If you have a Question​ or need More Information about our services, please send ​us your request and we will contact you soon